Development of Duodenal Ulcers due to the Discontinuation of Proton Pump Inhibitors After the Induction of Sofosbuvir Plus Ledipasvir Therapy: A Report of Two Cases

Utilization and efficacy of elbasvir/grazoprevir for treating hepatitis C virus infection after liver transplantation

“…). Grade 3 or higher adverse events were not observed in the patients on DCV/ASV therapy, whereas duodenal ulcers due to discontinuation of proton pump inhibitor were observed in two patients on SOF/LDV therapy …”